Eads & Heald Wealth Management Grows Holdings in The Clorox Company (NYSE:CLX)

Eads & Heald Wealth Management increased its position in The Clorox Company (NYSE:CLX) by 2.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,129 shares of the company’s stock after buying an additional 180 shares during the period. Eads & Heald Wealth Management’s holdings in Clorox were worth $1,320,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of CLX. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox in the 3rd quarter worth about $27,000. Continuum Advisory LLC grew its holdings in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Quarry LP increased its stake in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new position in shares of Clorox during the 3rd quarter worth about $48,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several research analyst reports. Evercore ISI dropped their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Barclays reduced their target price on Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. JPMorgan Chase & Co. upped their price target on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Finally, Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, Clorox has an average rating of “Hold” and an average target price of $156.54.

Clorox Trading Down 0.2 %

Clorox stock opened at $160.03 on Wednesday. The stock has a market cap of $19.81 billion, a price-to-earnings ratio of 55.76, a price-to-earnings-growth ratio of 2.95 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The business has a 50 day moving average price of $164.16 and a two-hundred day moving average price of $156.91. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.49 earnings per share. As a group, equities analysts forecast that The Clorox Company will post 6.87 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.05%. Clorox’s payout ratio is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.